CAMP4 Therapeutics Corporation (CAMP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

CAMP4 Therapeutics Corpor...

NASDAQ: CAMP · Real-Time Price · USD
1.49
0.01 (0.68%)
At close: Sep 05, 2025, 3:59 PM
1.53
2.68%
After-hours: Sep 05, 2025, 05:46 PM EDT

CAMP4 Therapeutics Income Statement

Financials in USD. Fiscal year is March - February.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Nov 30, 2023 Feb 28, 2023 Feb 28, 2022
Revenue
652K 186.23M 294.95M 295.84M
Cost of Revenue
n/a 119.25M 185.94M 173.95M
Gross Profit
652K 66.98M 109.01M 121.89M
Operating Income
-53.09M -8.72M -21.48M -15.31M
Interest Income
1.33M 2.81M n/a n/a
Pretax Income
-51.79M -92.74M -31.34M -30.06M
Net Income
-51.79M -93.26M -32.49M -31.15M
Selling & General & Admin
14.92M 61.01M 99.21M 100.9M
Research & Development
38.82M 14.69M 24.57M 28.44M
Other Expenses
n/a n/a 5.33M 5.42M
Operating Expenses
53.74M 75.7M 129.11M 134.76M
Interest Expense
n/a n/a 6.26M 15.32M
Selling & Marketing Expenses
n/a 29.52M 47.39M 48.56M
Cost & Expenses
53.74M 194.95M 315.05M 308.71M
Income Tax Expense
n/a -525K 1.15M 1.09M
Shares Outstanding (Basic)
19.51M 37.02M 36.1M 35.25M
Shares Outstanding (Diluted)
19.51M 37.02M 36.13M 35.25M
EPS (Basic)
-2.66 -2.52 -0.9 -0.88
EPS (Diluted)
-2.66 -2.52 -0.9 -0.88
EBITDA
-51.39M -8.72M 276K 7.49M
EBIT
-53.09M n/a -21.48M -15.31M
Depreciation & Amortization
1.7M n/a 21.76M 22.8M